首页 | 本学科首页   官方微博 | 高级检索  
检索        


Pretreatment laparotomy in carcinoma of the cervix
Authors:Charles E Welander MD  Virginia K Pierce MD  Dattatreyudu Nori MD  Basil S Hilaris MD  Cynthia Kosloff MS  Donald GC Clark MD  Walter B Jones MD  Woo Shin Kim MD  John L Lewis Jr MD  
Institution:1. Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 U.S.A.;2. Department of Radiation Therapy, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 U.S.A.;3. Biostatistics Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 U.S.A.;4. American Cancer Society Clinical Fellow, Gynecologic Oncology, Department of Surgery, Memorial Sloan-Kettering Cancer Center U.S.A.
Abstract:In cases of advanced carcinoma of the uterine cervix, control of regional pelvic disease is not always equated with survival. While early disease often does remain localized within the pelvis, more advanced cervical cancers are observed to metastasize to paraaortic nodes and to distant sites. This study reports a surgical protocol designed to define extent of disease in patients having invasive cervical carcinoma prior to administering primary radiation therapy. Three questions have been raised: (1) Which individual patients have disease outside the pelvis? (2) Is it possible to modify therapy to control disease outside the pelvis and thereby influence survival? (3) Are positive paraaortic nodes found at pretreatment laparotomy indicative of systemic spread of disease? This pretreatment laparotomy was done on 127 patients, 31 of whom were found to have positive paraaortic nodes (24.4%). Sixteen patients had metastatic disease within the peritoneal cavity. Standard pelvic radiotherapy was subsequently given, supplemented with a paraaortic field in those cases with positive paraaortic nodes. Survival was not significantly different in patients with or without paraaortic nodal disease. It was further noted that 17 of the 31 patients (54.8%) who had positive paraaortic nodes later had distant metastases (median time 8 months), compared to 2496 (25.0%) with negative nodes having a median time to metastases of 10 months.
Keywords:To whom reprint requests should be addressed at: Memorial Sloan-Kettering Cancer Center  1275 York Ave    New York  N  Y  10021  
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号